Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production
B. Kessler et al., Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production, J IMMUNOL, 161(12), 1998, pp. 6939-6946
This study describes a form of partial agonism for a CD8(+)CTL clone, S15,
in which perforin-dependent killing and IFN-gamma production were lost but
Fas (APO1 or CD95)-dependent cytotoxicity preserved. Cloned S15 CTL are H-2
K(d) restricted and specific for a photoreactive derivative of the Plasmodi
um berghei circumsporozoite peptide PbCS 252-260 (SYIPSAEKI), The presence
of a photoactivatable group in the epitope permitted assessment of TCR-liga
nd binding by TCR photoaffinity labeling. Selective activation of Pas-depen
dent killing was observed for a peptide-derivative variant containing a mod
ified photoreactive group. A similar functional response was obtained after
binding of the wild-type peptide derivative upon blocking of CD8 participa
tion in TCR-ligand binding. The epitope modification or blocking of CD8 res
ulted in an greater than or equal to 8-fold decrease in TCR-ligand binding.
In both cases, phosphorylation of zeta-chain and ZAP-70, as well as calciu
m mobilization were reduced close to background levels, indicating that act
ivation of Pas-dependent cytotoxicity required weaker TCR signaling than ac
tivation of perforin-dependent killing or IFN-gamma production. Consistent
with this, we observed that depletion of the protein tyrosine kinase p56(lc
k) by preincubation of S15 CTL with herbimycin A severely impaired perforin
- but not Pas-dependent cytotoxicity. Together with the observation that S1
5 CTL constitutively express Pas ligand, these results indicate that TCR si
gnaling too weak to elicit perforin-dependent cytotoxicity or cytokine prod
uction can induce Fas-dependent cytotoxicity, possibly by translocation of
preformed Fas ligand to the cell surface.